Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > WallStreet Research Initiates Coverage of BioSante Pharmaceuticals

March 26th, 2004

WallStreet Research Initiates Coverage of BioSante Pharmaceuticals

Abstract:
WallStreet Research led by Alan Stone, Managing Director of Alan Stone & Company, LLC, announced today that it has released an analyst research report initiating coverage of BioSante Pharmaceuticals, Inc. The complete analyst research report on BioSante Pharmaceuticals, Inc., together with the risks associated therewith and additional information about WallStreet Research is available online.

Source:
Businesswire

Bookmark:

Related News Press

Financial Reports

Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013

Harris & Harris Group Reports Financial Statements as of March 31, 2013 May 10th, 2013

Arrowhead Reports Fiscal 2013 Second Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time May 9th, 2013

Arrowhead to Report Fiscal 2013 Second Quarter Financial Results - Conference Call Scheduled for Thursday, May 9, 2013 May 2nd, 2013